Literature DB >> 15831642

Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones.

M U Braun1, T Rauwolf, T Zerm, M Schulze, A Schnabel, R H Strasser.   

Abstract

OBJECTIVE: To assess prospectively the effect of cardiac resynchronisation therapy (CRT) on New York Heart Association (NYHA) functional class, cardiac function, cardiopulmonary exercise performance, and neurohormonal activation during 24 months' follow up.
DESIGN: Controlled study. PATIENTS AND
RESULTS: 124 patients with severe congestive heart failure (ejection fraction < 35%, NYHA III-IV) and left bundle branch block (QRS duration > 150 ms) were enrolled (control group, n = 59; CRT group, n = 65) and followed up at 1, 3, 12, and 24 months. Compared with the control group, CRT led to significant short and long term improvements in functional NYHA functional class (mean (SEM) 2.1 (0.4) v 2.8 (0.4) at 24 months, p < 0.05), mean ejection fraction (25.7 (4)% v 21.1 (5)% at 24 months, p < 0.05), peak Vo(2) (16.8 (3.9) v 12.6 (3.5) ml/kg x min at 24 months, p < 0.01), and Vo(2) at anaerobic threshold (14.4 (3.7) v 10.8 (3.2) ml/kg x min at 24 months, p < 0.05). In addition, CRT for one and 12 months significantly decreased the plasma concentrations of noradrenaline (norepinephrine) and N-terminal fragment of pro-brain natriuretic peptide, whereas no changes were observed for other neurohormones such as antidiuretic hormone, aldosterone, and endothelin.
CONCLUSION: Long term CRT (<or= 24 months) results in significant improvement of NYHA class and cardiopulmonary exercise capacity and a short term decrease in neurohormonal activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831642      PMCID: PMC1768894          DOI: 10.1136/hrt.2003.030338

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

1.  Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling.

Authors:  Leslie A Saxon; Teresa De Marco; Jill Schafer; Kanu Chatterjee; Uday N Kumar; Elyse Foster
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

2.  Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study.

Authors:  Daniel Gras; Christophe Leclercq; Anthony S L Tang; Cliff Bucknall; Henk Oude Luttikhuis; Anders Kirstein-Pedersen
Journal:  Eur J Heart Fail       Date:  2002-06       Impact factor: 15.534

3.  Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

Authors:  Wendy Johnson; Torbjørn Omland; Christian Hall; Caroline Lucas; Ole L Myking; Caroline Collins; Marc Pfeffer; Jean-Lucien Rouleau; Lynne W Stevenson
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

4.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Authors:  B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

5.  Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients.

Authors:  C Butter; A Auricchio; C Stellbrink; E Fleck; J Ding; Y Yu; E Huvelle; J Spinelli
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

Review 6.  Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.

Authors:  A Kjaer; B Hesse
Journal:  Clin Physiol       Date:  2001-11

7.  Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy.

Authors:  Mohamed H Hamdan; Saverio Barbera; Robert C Kowal; Richard L Page; Karthik Ramaswamy; Jose A Joglar; Valeh Karimkhani; Michael L Smith
Journal:  Am J Cardiol       Date:  2002-05-01       Impact factor: 2.778

8.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

Authors:  Samuele Baldasseroni; Cristina Opasich; Marco Gorini; Donata Lucci; Niccolò Marchionni; Maurizio Marini; Carlo Campana; Giampaolo Perini; Antonella Deorsola; Giulio Masotti; Luigi Tavazzi; Aldo P Maggioni
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

9.  Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay.

Authors:  Angelo Auricchio; Jiang Ding; Julio C Spinelli; Andrew P Kramer; Rodney W Salo; Walter Hoersch; Bruce H KenKnight; Helmut U Klein
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

10.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Authors: 
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

View more
  9 in total

Review 1.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy.

Authors:  Martin U Braun; Andreas Schnabel; Thomas Rauwolf; Matthias Schulze; Ruth H Strasser
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

3.  Effect of cardiac resynchronization therapy on broad neurohormone biomarkers in heart failure.

Authors:  Ying-Xue Dong; John C Burnett; Horng H Chen; Sharon Sandberg; Yan-Zhong Yang; Yanhua Zhang; Peng-Sheng Chen; Yong-Mei Cha
Journal:  J Interv Card Electrophysiol       Date:  2011-02-19       Impact factor: 1.900

4.  Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.

Authors:  Abhishek Bose; Quynh A Truong; Jagmeet P Singh
Journal:  J Interv Card Electrophysiol       Date:  2015-02-27       Impact factor: 1.900

5.  Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.

Authors:  Alaa A Shalaby; William T Abraham; Gregg C Fonarow; Malcolm M Bersohn; John Gorcsan; Li-Yin Lee; Jasmina Halilovic; Samir Saba; Alan Maisel; Jagmeet P Singh; Ali Sonel; Alan Kadish
Journal:  Pacing Clin Electrophysiol       Date:  2015-03-30       Impact factor: 1.976

6.  Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea.

Authors:  Lars Lüthje; Bernd Renner; Roger Kessels; Dirk Vollmann; Tobias Raupach; Bart Gerritse; Selcuk Tasci; Jörg O Schwab; Markus Zabel; Dieter Zenker; Peter Schott; Gerd Hasenfuss; Christina Unterberg-Buchwald; Stefan Andreas
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

7.  Cardiac resynchronization therapy upregulates cardiac autonomic control.

Authors:  Yong-Mei Cha; Jae Oh; Chinami Miyazaki; David L Hayes; Robert F Rea; Win-Kuang Shen; Samuel J Asirvatham; Brad J Kemp; David O Hodge; Peng-Sheng Chen; Panithaya Chareonthaitawee
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-09

8.  The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker.

Authors:  I A H Ter Horst; J van 't Sant; S C Wijers; M A Vos; M J Cramer; M Meine
Journal:  Neth Heart J       Date:  2016-03       Impact factor: 2.380

9.  Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.

Authors:  Z Bakos; N C Chatterjee; C Reitan; J P Singh; R Borgquist
Journal:  BMC Cardiovasc Disord       Date:  2018-04-24       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.